Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-513530-37-00Phase 3Authorised
Phase 3, randomised trial of isoflurane and propofol in delirium (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Occurrence of delirium in intensive care unit. Planned start Aug 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-513530-37-00.